TAS-114

DRUG2 trials

Sponsors

Taiho Oncology, Inc.

Conditions

Advanced Solid TumorsAdvanced or Metastatic Non-small Cell Lung Cancer

Phase 1

A Trial of TAS-114 in Combination With S-1

CompletedNCT02454062

Taiho Oncology, Inc.Advanced Solid Tumors

Start: 2013-03-31End: 2017-09-30Updated: 2024-09-04

Phase 2

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

CompletedNCT02855125

Taiho Oncology, Inc.Advanced or Metastatic Non-small Cell Lung Cancer

Start: 2016-08-29End: 2017-11-30Updated: 2024-09-19

Related Papers

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer.

2020-04-0313 citations

First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors.

2018-12-0412 citations

Abstract CT014: A large phase I study of TAS-114 in combination with S-1 in patients with advanced solid tumors

Cancer Research2018-07-014 citations